Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I will buy more. I know a friend who has 1MM shares of Zalicus. Lol
You are rich! Lol
I will mark this post.
You do not forget about the discovery of Mark Versavel.
Now I can not. Then later.
It would make us rich, very rich bro.
Or new collaboration with Pfizer (cHTS)!
Do you have seen link? This link is spectacular.
They said at the conference that come good news
I will add 30k shares.
Tomorrow $ZLCS go to $0.7
Novartis clinical trials (cancer) with combination of drugs (cHTS) link:
http://clinicaltrials.gov/ct2/results?term=novartis+cancer+combination&Search=Search
You look in clinicaltrials.gov Novartis has 346 developments with drugs combination in the fight against cancer. Awesome news for Zalicus.
Nice connection. He work in Zalicus for development of Z160 $$$$$$$$!!!!!
$ZLCS- Thanks. We'll be rich in no time with Zalicus.
$ZLCS- Zalicus with this valuation = $20 per share in 2014.
Z160= $1 billion Z944= $1 billion Partnering with Novartis= $500 million + Prednisporin= $50 million + Exalgo= $200 million. Zalicus is strong undervalued.
Do you know Z944 sodium ion channel? This is an orphan drug with SPA agreement in 2013. I am sure.
Z160 is $1 billion drug. Blockbuster.
I like Pfizer. Is my favorite candidate.
Pfizer? Cubist? Biogen? lol time to reload!
Lol What will be the next?
This is the key! The strong cancer research collaboration with Novartis.
2 clinical trials of Novartis in phase III! Possible results in January and February!
= $$$$$$$$$$$ for Zalicus!
He know information. For this reason, he is accumulate
From YMB about Zalicus and Novartis clinical trials :
Just a few that have recently been updated and are fairly new since the collaboration started. Looks like the Novartis partnership is alive and well. Too many to list here. The list goes on and on......
Just look at clinical trials(dot)gov and you will find a boat load of combination drug trials for cancer and there genotypes. This certainly lines up to what Mr. Corrigan referred to at the ASCO-NCI-EORTC Molecular Markers meeting.
Not yet open to enrollment-6/2012- A Phase IIIB, Multi-Center, Open Label Study For Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) in Combination With Exemestane: 4EVER
Currently recruiting-4/2011- A Phase Ib, Open-label, Multi-center, Dose-escalation and Expansion Study of an Orally Administered Combination of BEZ235 Plus MEK162 in Adult Patients With Selected Advanced Solid Tumors
10/2010- A Phase IA, Multicenter, Open-label Dose Escalation Study of Oral BYL719, in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
5/2012- A Phase I Study of LJM716 in Patients With Squamous Cell Carcinoma of Head and Neck, or HER2 Overexpressing Metastatic Breast Cancer or Gastric Cancer
9/2011-An Open-label, Multi-center Phase I Dose-finding Study of RAD001 (Everolimus, Afinitor?) in Combination With BEZ235 in Patients With Advanced Solid Tumors
6/2010-A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral BKM120 in Combination With Oral GSK1120212 in Adult Patients With Selected Advanced Solid Tumors.
5/2012-A Multicenter, Open-label, Dose Escalation, Phase I Study of LJM716 Administered Intravenously in Combination With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast Cancer
You can search in facebook: Mark Versavel. He work in Zalicus but he also worked in Pfizer from Lyrica development.
Thanks for your recommendation.
I like you strategy in Zalicus.
You are a shark.
Glad to hear it. They have high hopes with future sales of Exalgo 32mg.
200k? Planning to buy more? Lol
Big blocks!
Yesterday, I added 15k shares.
Novartis, Amgen, Eisai, big players in Zalicus. I think in Pfizer with Z160. They could be paid $500MM for the worldwide license. You can see the historical agreement with Merck in Neuromed.
Novartis and Zalicus could be the most important cancer research in the world with cHTS system.
The chart mark the same figure in $ZLCS
Zalicus have 2 cancer patents with Novartis. With new clinical trial about cancer research Novartis paid $20MM to Zalicus...
He continue accumulating... Oppenheimer? JPM?